Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.53B |
| 2 |
Eli Lilly
LLY
|
+$874M |
| 3 |
Blackstone
BX
|
+$706M |
| 4 |
RTX Corp
RTX
|
+$576M |
| 5 |
American Express
AXP
|
+$574M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.43B |
| 2 |
American Tower
AMT
|
+$1.25B |
| 3 |
Amazon
AMZN
|
+$785M |
| 4 |
TSS
Total System Services, Inc.
TSS
|
+$714M |
| 5 |
Apple
AAPL
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.49% |
| 2 | Financials | 15.09% |
| 3 | Technology | 13.78% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOV
1001
DELISTED
Myovant Sciences Ltd.
MYOV
| $17.8M | ﹤0.01% |
3,431,591
-211,847
| -6% | -$1.57M |
|
|
VSM
1002
DELISTED
Versum Materials, Inc.
VSM
| $17.6M | ﹤0.01% |
331,979
+52,881
| +19% | +$2.75M |
|
1003
Stellantis
STLA
$21.1B
| $17.5M | ﹤0.01% |
1,351,732
+583,057
| +76% | +$7.8M |
|
1004
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
| $17.5M | ﹤0.01% |
379,295
-113,832
| -23% | -$5.21M |
|
|
MODV
1005
DELISTED
ModivCare
MODV
| $17.4M | ﹤0.01% |
292,264
-57,375
| -16% | -$3.27M |
|
|
MRO
1006
DELISTED
Marathon Oil Corporation
MRO
| $17.3M | ﹤0.01% |
1,411,535
-885,329
| -39% | -$11.4M |
|
1007
The Mosaic Company
MOS
$7.41B
| $17.3M | ﹤0.01% |
842,116
+41,293
| +5% | +$899K |
|
1008
Tyson Foods
TSN
$20.1B
| $17.2M | ﹤0.01% |
200,121
+2,479
| +1% | +$211K |
|
1009
Ligand Pharmaceuticals
LGND
$6.33B
| $17.1M | ﹤0.01% |
275,431
-10,414
| -4% | -$654K |
|
1010
LGI Homes
LGIH
$1.32B
| $17M | ﹤0.01% |
203,915
+34,795
| +21% | +$2.66M |
|
1011
Fabrinet
FN
$19.1B
| $17M | ﹤0.01% |
324,400
-66,746
| -17% | -$3.5M |
|
1012
ePlus
PLUS
$2.37B
| $16.9M | ﹤0.01% |
445,162
-109,276
| -20% | -$4.21M |
|
|
HAYN
1013
DELISTED
Haynes International, Inc.
HAYN
| $16.9M | ﹤0.01% |
471,858
+132,278
| +39% | +$4.19M |
|
1014
RingCentral
RNG
$5.4B
| $16.9M | ﹤0.01% |
134,301
-5,320
| -4% | -$697K |
|
|
MDSO
1015
DELISTED
Medidata Solutions, Inc.
MDSO
| $16.9M | ﹤0.01% |
184,184
-148,999
| -45% | -$13.6M |
|
|
CBIO
1016
Crescent Biopharma
CBIO
$641M
| $16.6M | ﹤0.01% |
38,573
-9,050
| -19% | -$5.82M |
|
|
KL
1017
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $16.6M | ﹤0.01% |
370,763
+64,231
| +21% | +$2.93M |
|
|
TRHC
1018
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $16.6M | ﹤0.01% |
302,101
+15,768
| +6% | +$902K |
|
1019
VanEck Gold Miners ETF
GDX
$27.6B
| $16.6M | ﹤0.01% |
620,999
+468,643
| +308% | +$13.1M |
|
|
AKCA
1020
DELISTED
Akcea Therapeutics Inc
AKCA
| $16.5M | ﹤0.01% |
1,071,686
-47,172
| -4% | -$1M |
|
1021
Fortinet
FTNT
$121B
| $16.5M | ﹤0.01% |
1,072,275
-1,864,955
| -63% | -$30.3M |
|
|
PHAS
1022
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $16.3M | ﹤0.01% |
3,912,727
+17,514
| +0.4% | +$140K |
|
|
FRBK
1023
DELISTED
Republic First Bancorp Inc
FRBK
| $16.3M | ﹤0.01% |
3,874,289
-108,640
| -3% | -$472K |
|
1024
Endava
DAVA
$161M
| $16.2M | ﹤0.01% |
429,077
-78,873
| -16% | -$3.02M |
|
1025
Grupo Cibest SA
CIB
$21.8B
| $16.2M | ﹤0.01% |
327,443
-18,284
| -5% | -$923K |
|
Similar funds
Wellington Management Group's Q3 2019 Portfolio in Review
As of Q3 2019, Wellington Management Group held 2,207 positions worth $443B, down 1.8% from $452B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q3 2019 filing shows 166 new, 707 increased, 1,000 reduced and 194 closed positions. Its largest new stake was Cable One: 145,948 shares worth $183M. The largest sale was Allergan plc, an estimated $3.43B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q3 2019 buy was Cable One: 145,948 shares worth $183M.
- Wellington Management Group added most to Pfizer in Q3 2019, an estimated $1.53B increase.
- Wellington Management Group's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $3.43B.
- Wellington Management Group fully exited Total System Services, Inc. in Q3 2019, selling an estimated $714M.
- Wellington Management Group's ten largest holdings make up 15% of its $443B portfolio in Q3 2019.
- Wellington Management Group opened 166 new positions and closed 194 in Q3 2019.
- Wellington Management Group's portfolio value fell 1.8% quarter-over-quarter to $443B.
Based on Wellington Management Group's 13F filing for Q3 2019, filed 13 Nov 2019.